Gall Matthew 4
4 · iTeos Therapeutics, Inc. · Filed Jun 16, 2021
Insider Transaction Report
Form 4
Gall Matthew
Chief Financial Officer
Transactions
- Purchase
Common Stock
2021-06-16$26.09/sh+5,000$130,447→ 5,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $25.84 to $26.15. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.